{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-168332","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2022-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.688535+00:00","generated_at":"2026-06-25T04:27:48.444207+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cytek Biosciences reports 2022 annual meeting voting results; Class I directors elected and auditor ratified","bullets":["Deborah Neff and Don Hardison elected as Class I directors with ~88.7M and ~88.7M votes for, respectively.","Ratification of Deloitte & Touche as auditor for FY2022 approved with 115.4M votes for, 5,450 against.","Approximately 86% of outstanding shares (116M out of 134.2M) represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-168332","json":"https://secwatch.observer/filing/0001193125-22-168332.json","markdown":"https://secwatch.observer/filing/0001193125-22-168332.md","text":"https://secwatch.observer/filing/0001193125-22-168332.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522168332/0001193125-22-168332-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522168332/d367623d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:27:48.444207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}